PortfoliosLab logo
DAVE vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between DAVE and LLY is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

DAVE vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dave Inc. (DAVE) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%400.00%December2025FebruaryMarchAprilMay
-66.60%
357.74%
DAVE
LLY

Key characteristics

Sharpe Ratio

DAVE:

1.45

LLY:

0.17

Sortino Ratio

DAVE:

2.34

LLY:

0.50

Omega Ratio

DAVE:

1.29

LLY:

1.07

Calmar Ratio

DAVE:

1.42

LLY:

0.26

Martin Ratio

DAVE:

5.56

LLY:

0.53

Ulcer Index

DAVE:

23.90%

LLY:

12.18%

Daily Std Dev

DAVE:

92.14%

LLY:

37.71%

Max Drawdown

DAVE:

-99.01%

LLY:

-68.27%

Current Drawdown

DAVE:

-77.11%

LLY:

-14.14%

Fundamentals

Market Cap

DAVE:

$1.40B

LLY:

$739.60B

EPS

DAVE:

$4.19

LLY:

$12.27

PE Ratio

DAVE:

24.99

LLY:

67.12

PS Ratio

DAVE:

4.03

LLY:

15.09

PB Ratio

DAVE:

7.63

LLY:

46.91

Total Revenue (TTM)

DAVE:

$273.45M

LLY:

$49.00B

Gross Profit (TTM)

DAVE:

$226.28M

LLY:

$40.03B

EBITDA (TTM)

DAVE:

$33.69M

LLY:

$16.67B

Returns By Period

In the year-to-date period, DAVE achieves a 20.51% return, which is significantly higher than LLY's 6.59% return.


DAVE

YTD

20.51%

1M

47.95%

6M

178.07%

1Y

132.06%

5Y*

N/A

10Y*

N/A

LLY

YTD

6.59%

1M

11.28%

6M

2.25%

1Y

12.49%

5Y*

41.19%

10Y*

29.83%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

DAVE vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DAVE
The Risk-Adjusted Performance Rank of DAVE is 8888
Overall Rank
The Sharpe Ratio Rank of DAVE is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of DAVE is 8989
Sortino Ratio Rank
The Omega Ratio Rank of DAVE is 8686
Omega Ratio Rank
The Calmar Ratio Rank of DAVE is 8989
Calmar Ratio Rank
The Martin Ratio Rank of DAVE is 8787
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 5555
Overall Rank
The Sharpe Ratio Rank of LLY is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 5050
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 5050
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 6363
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 5757
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

DAVE vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Dave Inc. (DAVE) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current DAVE Sharpe Ratio is 1.45, which is higher than the LLY Sharpe Ratio of 0.17. The chart below compares the historical Sharpe Ratios of DAVE and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.005.0010.00December2025FebruaryMarchAprilMay
1.45
0.17
DAVE
LLY

Dividends

DAVE vs. LLY - Dividend Comparison

DAVE has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.66%.


TTM20242023202220212020201920182017201620152014
DAVE
Dave Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.66%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%2.84%

Drawdowns

DAVE vs. LLY - Drawdown Comparison

The maximum DAVE drawdown since its inception was -99.01%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for DAVE and LLY. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-77.11%
-14.14%
DAVE
LLY

Volatility

DAVE vs. LLY - Volatility Comparison

Dave Inc. (DAVE) has a higher volatility of 25.31% compared to Eli Lilly and Company (LLY) at 22.46%. This indicates that DAVE's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%December2025FebruaryMarchAprilMay
25.31%
22.46%
DAVE
LLY

Financials

DAVE vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Dave Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B14.00B20212022202320242025
100.84M
12.73B
(DAVE) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

DAVE vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Dave Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%20212022202320242025
93.8%
82.5%
(DAVE) Gross Margin
(LLY) Gross Margin
DAVE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Dave Inc. reported a gross profit of 94.56M and revenue of 100.84M. Therefore, the gross margin over that period was 93.8%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.

DAVE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Dave Inc. reported an operating income of 20.99M and revenue of 100.84M, resulting in an operating margin of 20.8%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.

DAVE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Dave Inc. reported a net income of 16.81M and revenue of 100.84M, resulting in a net margin of 16.7%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.